Cross Licensing: A Strategy for Collaborative Innovation and Risk Mitigation

When two companies hold patents that each other needs, going to court isn’t always the answer. Sometimes, the smarter move is to simply swap access – you use mine, I’ll use yours. This is the core idea behind cross licensing, and it is far more consequential than it sounds. From semiconductor chip designs to 5G telecom standards, cross licensing quietly powers some of the most complex products in the modern economy. For law students studying intellectual property management in India, understanding how this mechanism works – and where it can go wrong – is essential.

What cross licensing actually means 🔗

A cross licensing agreement is a mutual arrangement where two or more parties grant each other the right to use their respective patents. Unlike a standard one-way license, where a licensee pays royalties to a licensor, cross licensing creates a reciprocal relationship – each party acts simultaneously as both licensor and licensee. While patents are the most common subject matter, such agreements can also cover copyrights and trademarks in some cases.

These agreements can take different structural forms. Some are royalty-free, where parties simply exchange access without any financial payment. Others are royalty-bearing, especially when the value of the patent portfolios being exchanged is not equal – the party receiving more valuable IP may pay the difference. Agreements can also be narrow in scope, covering only specific patents for defined applications, or broad, granting access to an entire portfolio.

In India, the legal backbone for these arrangements is the Patents Act, 1970. Section 68 requires that any patent license be in writing and properly executed. Section 69 mandates registration of the license agreement with the Patent Office to make it enforceable against third parties. These are not optional formalities – failure to register can leave a cross license legally exposed.

Why companies choose cross licensing 🔗

Avoiding the patent thicket problem 🔗

In technology-intensive industries, any single product may rely on dozens or even hundreds of separately patented components. A smartphone, for instance, incorporates inventions related to display technology, wireless communication, battery management, touch sensitivity, and more – each potentially owned by a different entity. Without cross licensing, manufacturers would need to individually negotiate with every patent holder before bringing a product to market. This phenomenon, where dense patent ownership makes commercialization extremely difficult, is called a patent thicket.

Cross licensing cuts through this problem. By entering into reciprocal agreements, companies can assemble the full basket of technologies they need without triggering infringement claims at every step. This approach allows companies to overcome the barriers of high R&D costs and limited access to cutting-edge technologies, particularly in sectors like biotechnology, pharmaceuticals, and information technology.

Reducing litigation costs and risk 🔗

Patent litigation in India is notoriously time-consuming and expensive. Disputes can stretch for years through the courts, consuming resources that could otherwise go toward research and product development. Cross licensing offers a practical off-ramp from this cycle. Companies can resolve existing patent disputes and simultaneously set up a framework to prevent future conflicts – sometimes including provisions for how new patents developed by either party will be treated going forward.

For Indian businesses, the economic logic is straightforward: cross licensing mitigates costs associated with patent litigation and licensing fees, allowing companies to redirect resources toward their core operations and competitive priorities.

Accelerating innovation through collaboration 🔗

Beyond cost savings, cross licensing has a deeper effect on the pace of innovation itself. When companies can legally access and build upon each other’s patents, researchers are not forced to spend time and money engineering around existing IP. Instead, they can work directly with established technological building blocks to create genuinely new advances. This collaborative dynamic is especially visible in biotechnology, where research is inherently incremental – each discovery building on prior work. Cross licensing removes legal friction from this process.

India’s growing emphasis on R&D across sectors like clean energy, pharmaceuticals, and electronics makes this function of cross licensing particularly relevant. The more efficiently companies can access complementary technologies, the more they can invest in genuinely novel development.

Cross licensing and industry standards 🔗

One of the most important – and legally complex – arenas where cross licensing operates is in the development and implementation of industry standards. When standard-setting organisations (SSOs) develop technical standards for products like Wi-Fi, Bluetooth, or 4G/5G protocols, they often incorporate patented technologies from multiple companies. Patents that are essential to implementing a recognised standard are known as Standard Essential Patents (SEPs).

Once a technology becomes embedded in a standard, the patent holder gains significant market power – any manufacturer building a compliant product must use that technology. To prevent abuse of this position, SSOs require patent holders to commit to licensing their SEPs on FRAND terms – Fair, Reasonable, and Non-Discriminatory. Cross licensing plays a critical role in how companies navigate this landscape, allowing telecom equipment manufacturers, for example, to manage SEP obligations across multiple patent holders without individually negotiating each one.

India, with the world’s second largest telecommunication network, has been at the centre of high-profile SEP disputes. The landmark case of Micromax Informatics Ltd. v. Telefonaktiebolaget LM Ericsson brought these issues squarely before the Competition Commission of India (CCI). Micromax alleged that Ericsson was abusing its dominant position by charging excessive royalties for SEP licenses and insisting on non-disclosure agreements as a condition of licensing. The CCI found the practices discriminatory and directed an investigation under the Competition Act, 2002.

This case established a critical principle in Indian IPR management: a patent holder’s failure to license on FRAND terms can constitute an abuse of dominant position, making it reviewable under both patent law and competition law. Cross licensing arrangements that involve SEPs must therefore be crafted with this dual legal framework in mind.

The competitive risks: barriers for new entrants 🔗

Cross licensing is not without its darker side. While established players can exchange large patent portfolios on relatively equal terms, startups and new market entrants typically lack the patent assets needed to offer anything in return. This creates an inherent asymmetry: large incumbents build an ecosystem of cross licenses among themselves, effectively raising the cost of entry for anyone outside the arrangement.

A new company attempting to enter the semiconductor or telecom space, for instance, may find that key technologies are locked within cross licensing agreements it cannot join. It would have to either pay royalties without the benefit of reciprocity, or develop workarounds – both of which drain resources and slow down market entry. The Indian market is dominated by small-scale SEP-implementers, SMEs, and startups who are particularly vulnerable to this dynamic.

This concern is recognised under Indian law. Section 3 of the Competition Act, 2002 prohibits anti-competitive agreements that cause or are likely to cause an appreciable adverse effect on competition. Cross licensing agreements that unreasonably restrict trade, create barriers to entry, or facilitate price coordination can attract scrutiny from the CCI. The Commission evaluates such arrangements by weighing their pro-competitive benefits – like facilitating innovation and reducing litigation – against their potential to foreclose market access.

In practice, the line between legitimate cross licensing and anti-competitive conduct is not always obvious. Grant-back clauses – provisions requiring a licensee to share any improvements it develops with the original licensor – can significantly chill innovation incentives if drafted too broadly. Similarly, cross licenses that effectively bundle pricing information between competitors can raise cartel-like concerns. These are the structural details that make IP management both a legal and a strategic discipline.

Structuring a cross license: key considerations 🔗

A well-drafted cross licensing agreement goes well beyond simply listing the patents being exchanged. It needs to address several practical and legal dimensions.

Scope and field of use define exactly which patents are included and for what purposes they can be used. A company may be willing to cross-license its patents for use in consumer electronics but not in defence or medical devices. Territorial reach is equally important – a license in India does not automatically extend to patents registered in the US or Europe. Since patents are territorial rights, each jurisdiction must be addressed.

Valuation becomes critical when the portfolios being exchanged are not equal in value. Independent patent valuation, sometimes involving technical experts, determines whether a royalty payment is needed to balance the exchange. Duration and renewal terms specify how long the agreement runs and what happens when a party’s portfolio changes – new patents may be filed, existing ones may expire, and the agreement should have mechanisms to account for this.

Finally, dispute resolution clauses are essential. If one party believes the other is exceeding the scope of the license or failing to honour the terms, the agreement should specify whether disputes go to arbitration, courts, or the Controller of Patents. Under Indian law, the Controller has the power to direct compulsory licensing under Sections 84-92 of the Patents Act in certain circumstances, which can affect the negotiating dynamics even in voluntary cross licensing discussions.

Cross licensing in key Indian industries 🔗

In pharmaceuticals, cross licensing often involves platform technologies, manufacturing processes, and research tools. Indian generic drug manufacturers have used such arrangements to access production methods while managing existing patent obligations. The compulsory licensing framework under the Patents Act adds a further layer – it ensures that even where voluntary cross licensing fails, public health access to essential medicines is not entirely blocked.

In telecommunications, as discussed above, cross licensing is practically unavoidable. The rollout of 4G and 5G networks in India requires access to thousands of SEPs owned by global companies like Ericsson, Nokia, and Qualcomm. Indian telecom equipment manufacturers must navigate these complex patent relationships while complying with FRAND obligations – and cross licensing provides the primary mechanism for doing so.

In semiconductors and electronics, cross licensing is equally fundamental. Chip design involves highly interdependent innovations, and no single company holds all the patents it needs to manufacture a modern processor. Companies like Qualcomm and Intel routinely exchange patent rights globally, and Indian firms entering this space – whether in chip design, electronics manufacturing, or IoT – will increasingly need to engage with this ecosystem.

Balancing innovation and competition: the policy challenge 🔗

The deeper policy tension underlying cross licensing is the same one that runs through all of intellectual property law: how to reward innovation without restricting access. Patents exist to incentivise investment in R&D by granting temporary monopolies. Cross licensing makes those monopolies more workable in practice. But if cross licensing becomes a tool for incumbents to collectively manage markets and exclude rivals, it undermines the very competition that drives long-term innovation.

India’s National IPR Policy, announced in 2016 under the Department for Promotion of Industry and Internal Trade (DPIIT), acknowledges this balance as a core priority. As India’s patent ecosystem matures – with over 100,000 patents granted in 2023-24 alone – the institutional capacity to evaluate cross licensing arrangements for their competitive effects will become increasingly important. The CCI and the courts will need to develop clearer jurisprudence on where the line falls between permissible IP management and anti-competitive coordination.

For law students and future IP practitioners, cross licensing sits at the intersection of contract law, patent law, and competition law. Getting it right requires not just drafting skills but an understanding of the technological landscape, market dynamics, and the strategic interests of all parties involved.

What do you think? As Indian startups increasingly operate in technology-intensive sectors, should the law provide them with a specific mechanism to access cross licensing arrangements dominated by large incumbents? And where should the Competition Commission of India draw the line between a cross licensing arrangement that promotes innovation and one that merely protects entrenched market positions?

References

1. https://depenning.com/blog/cross-licensing-agreements-a-strategic-tool-to-minimise-patent-conflicts/
2. https://www.ipindia.gov.in/Patents/patents
3. https://globalcompetitionreview.com/hub/sepfrand-hub/2025/article/india-seps-and-frand-litigation-policy-and-latest-developments
4. https://ksandk.com/competition/balancing-ip-rights-and-competition-law-in-india/
5. https://www.lexology.com/library/detail.aspx?g=f3288edc-c761-425c-9cb7-ec04eb7c3678
6. https://spicyip.com/2025/09/license-to-kill-innovation-problems-of-the-indian-sep-antitrust-gridlock.html
7. https://www.azbpartners.com/bank/the-intellectual-property-and-antitrust-review-india/
8. https://www.trade.gov/country-commercial-guides/india-protecting-intellectual-property